Alogliptin Impurity 12 is a pharmaceutical intermediate used in the manufacturing process of alogliptin, a compound for diabetes research. It is a structurally defined chemical with multiple ring systems and functional groups.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 2749281-73-8
N-Acetyl alogliptin
Pharmaceutical intermediate or metabolite
N-Boc Alogliptin
active pharmaceutical ingredient
3-(2-Cyanobenzyl) Alogliptin
pharmaceutical intermediate
Alogliptin Impurity 70
pharmaceutical intermediate for alogliptin
5-Aminopyrazole-4-carboxamide hemisulphate
Pharmaceutical intermediate for allopurinol impurities
N-(4-Oxocyclohexyl)acetamide
pharmaceutical intermediate
(s)-2-(1-aminoethyl)-5-bromophenol hydrochloride
Pharmaceutical intermediate
Glycine tert-butyl ester hydrochloride
Pharmaceutical intermediate for peptide synthesis
N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-1-methyl-2,6-dioxopyrimidin-4-yl]piperidin-3-yl]benzamide
YJMNTJGSDFBRQM-OAQYLSRUSA-N
CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCC[C@H](C3)NC(=O)C4=CC=CC=C4